Vaccines for human papillomavirus infection: a critical analysis.
This article takes a critical look at the pros and cons of human papillomavirus (HPV) vaccines. There is enough evidence to suggest that the prophylactic vaccines are efficacious in preventing various benign and malignant conditions (including cervical cancers) caused by HPV. Even though the vaccine is costly, hypothetical analysis has shown that HPV vaccination will be cost effective in the long run. Therapeutic HPV vaccines used to treat established disease are still undergoing evaluation in clinical studies, and results seem to be encouraging. Although several countries have started mandatory vaccination programs with the prophylactic HPV vaccines, conservatives have voiced concerns regarding the moral impact of such vaccination programs.
Department of Dermatology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry-605 006, India.
Amiya Kumar
AK
Nath
Devinder Mohan
DM
Thappa
D002986:Clinical Trials as Topic / Q000639:trends; D003218:Condylomata Acuminata / Q000191:economics / Q000276:immunology / Q000517:prevention & control; D005260:Female; D006801:Humans; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000191:economics / Q000276:immunology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000191:economics / Q000627:therapeutic use*
D053918:Papillomavirus Vaccines